An AstraZeneca spokeswoman said ... for many years a hub of the group’s research. The closure, while offset by the Cambridge investment, was ...

After years of delays and rising costs, AstraZeneca has formally unveiled its $1 billion R&D facility in Cambridge ... could one day become a biotech hub to rival Boston and San Francisco in ...

It joins a cluster of businesses seeking to make Cambridge a hub for life sciences research ... which promotes business development in the city. AstraZeneca worked with Oxford University to ...

AstraZeneca announced the new facility in March as part of wider plans to invest £650m across the UK. This would be split into £450m for the Speke project and a further £200m for Cambridge ...

AstraZeneca Plc will invest £650 million ($827 million) into Britain, expanding its Cambridge base and building a vaccine manufacturing plant near Liverpool. The drug-maker, which partnered with ...

LONDON (Reuters) – AstraZeneca is closing ... for many years a hub of the group’s research. The closure, while offset by the Cambridge investment, was also a blow to the British government.